Clinical & Translational Oncology

Papers
(The H4-Index of Clinical & Translational Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The new function of circRNA: translation109
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid71
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas69
Exosome-transmitted lncRNA PCGEM1 promotes invasive and metastasis in gastric cancer by maintaining the stability of SNAI143
A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer42
CDK1 promotes the stemness of lung cancer cells through interacting with Sox241
SEOM clinical guidelines for the treatment of head and neck cancer (2020)39
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy37
Immune cell infiltration features and related marker genes in lung cancer based on single-cell RNA-seq33
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials33
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review32
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer31
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes30
A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway30
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis29
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas28
Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer27
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism27
The emerging roles of exosomal circRNAs in diseases26
CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway26
Targeting GLS1 to cancer therapy through glutamine metabolism25
Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling25
Tumor microenvironment, immune response and post-radiotherapy tumor clearance25
Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer24
Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics24
Urinary microRNAs expression in prostate cancer diagnosis: a systematic review24
Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy24
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)24
0.32693481445312